Used in neuroscience and biomedical research to quantify neurokinin A levels in rat samples, particularly in studies related to neuroinflammation, pain pathways, and central nervous system disorders. Enables researchers to assess neuropeptide release in response to stimuli or pharmacological agents. Commonly applied in preclinical studies investigating stress, depression, epilepsy, and neurodegenerative diseases. Provides a sensitive and specific method for measuring NKA in tissue homogenates, cerebrospinal fluid, or cell culture supernatants. Supports high-throughput analysis in experimental models exploring neuroimmune interactions.